Health News

A gut bacterium may be quietly fueling depression through an unexpected chemical twist. Researchers found that when Morganella morganii interacts with a common pollutant, it produces a molecule that triggers inflammation—something strongly linked to depression. This finding helps explain how gut microbes can influence brain health at a molecular level. It also raises the possibility of new treatments that target the immune system rather than just the brain.

A newly confirmed mass grave in ancient Jordan offers chilling insight into one of history’s first pandemics. Hundreds of plague victims were buried within days, revealing how the Plague of Justinian devastated entire communities. The findings show that people who usually lived spread out across regions were suddenly concentrated in death. It’s a powerful reminder that pandemics don’t just spread disease—they reshape how societies live and collapse.

A rare group of adults over 80, known as SuperAgers, are rewriting what we thought was possible for the aging brain. With memory abilities comparable to people decades younger, their brains either resist or withstand the damage typically linked to Alzheimer’s disease. Decades of research reveal that their social lifestyles and unique brain biology may hold the key to preserving cognitive function. Scientists believe these insights could pave the way for new strategies to delay or even prevent dementia.

Scientists have identified two specific types of brain cells that behave differently in people with depression, offering a clearer picture of what is happening inside the brain. By analyzing donated brain tissue with advanced genetic tools, the researchers found changes in neurons linked to mood and stress, as well as in immune-related microglia cells. These differences point to disruptions in key brain systems and reinforce that depression is rooted in biology, not just emotions.

A new minimally invasive procedure may help people keep weight off after stopping popular drugs like Ozempic and semaglutide—something most patients struggle with. In a clinical trial, those who underwent a technique called duodenal mucosal resurfacing regained far less weight compared to others after discontinuing the medication. The procedure works by renewing the lining of the upper small intestine, potentially “resetting” metabolism and preserving the benefits of weight loss.

A new virus-fighting plastic film could transform everyday surfaces into invisible defenders against disease. Instead of relying on chemicals, this flexible material is covered in microscopic pillars that physically stretch viruses until they burst, rendering them harmless. In lab tests, it destroyed or disabled about 94% of virus particles within an hour, showing impressive effectiveness.

Scientists at UC Irvine have found a way to potentially reverse age-related vision loss by targeting the ELOVL2 “aging gene” and restoring vital fatty acids in the retina. Their experiments in mice show that supplementing with specific polyunsaturated fatty acids—not just DHA—can restore visual function and even reverse cellular aging signs.

A newly discovered virus hiding inside a common gut bacterium could help explain one of medicine’s long-standing mysteries: why a microbe found in both healthy people and cancer patients is linked to colorectal cancer. The research suggests that the interaction between bacteria and the viruses they carry may be key to understanding disease risk. It may even lead to future screening tests that detect cancer risk earlier.

A routine blood marker tied to inflammation may reveal Alzheimer’s risk years in advance. Scientists found that higher neutrophil levels—part of the body’s first immune response—were linked to a greater chance of developing dementia. The discovery suggests this common lab value could help flag at-risk individuals before symptoms appear. It also raises the possibility that immune cells themselves may be fueling the disease.

Scientists have discovered that combining two existing drugs can dramatically reduce liver fat linked to a common and often silent disease. The treatment not only improved liver health in animal models but also showed potential to lower heart-related risks. Interestingly, using lower doses of both drugs together worked just as well as higher doses alone. While promising, the findings still need to be tested in humans.